277
Generic Name: sitagliptin
Pill imprint 277 has been identified as Januvia 100 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy.
Januvia 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Januvia Images
- Generic Name:
- sitagliptin
- Imprint:
-
277
- Strength:
- 100 mg
- Color:
- Brown
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0277
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-5925 | A S Medication Solutions LLC (repackager) |
| 54868-5840 | Physicians Total Care Inc (repackager) |
| 35356-0103 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Januvia resources
Search Again
